Navigation Links
Cocaine addiction linked to voluntary drug use and cellular memory, UCSF study shows
Date:7/30/2008

Rats that voluntarily use cocaine show a persistent cellular memory in the brain's reward center even after several months of abstinence from the drug, while their involuntary counterparts had no such memory, according to a new study by researchers at the University of California, San Francisco.

The researchers conclude that the pharmacologic effects of cocaine alone are not enough to cause long-lasting cellular memories in the brain's reward circuit. The discovery by neuroscientists at UCSF's Ernest Gallo Clinic and Research Center appears in the July 31 issue of the journal "Neuron."

The study opens a window onto the significance of active choice in using cocaine and extends our understanding that addiction is caused by more than the pharmacological effects of a given drug, according to Antonello Bonci, MD, senior author of the paper, UCSF associate professor of neurology, Howard J. Weinberger Chair in Addiction Research and principal investigator at the Gallo Center.

"We know that environmental cues are significant in many addictions, including tobacco and alcohol, and contribute to relapses," Bonci said. "This study identifies the specific neuronal process involved and helps explain relapse even after rehabilitative therapy or long-term abstinence."

The researchers trained rats to self-administer cocaine, food or sucrose using a lever-pressing procedure. A separate group of rats also received passive researcher-administered cocaine. Neural activity was compared in brain tissue samples from the four groups and with samples from rats that had not experienced any rewards or training.

The study found that rats that learned to self-administer cocaine showed an increase in communication to dopamine neurons, which form the brain's key natural reward and motivational circuit, known as the ventral tegmental area (VTA).

In rats that self-administered cocaine, the increase in neuronal communication call
'/>"/>

Contact: Kristen Bole
kbole@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New treatment effective in counteracting cocaine-induced symptoms
2. Drug Detection Kits Manufactured By IDenta Corp. Shown During French Television Broadcast (at TF1) - Product Aids French Police In Bust of 600 Kilograms Of Cocaine
3. Cocaine Use Dulls Brains Sensitivity to Rewards
4. $2.2M NIH grant to develop drugs to suppress cocaine cravings
5. Catalyst Pharmaceutical Partners Announces Positive Phase II Trial Results for Vigabatrin in the Treatment of Cocaine Addiction
6. Cocaines effects on brain metabolism may contribute to abuse
7. Use of Methamphetamine Among U.S. Workers and Job Applicants Drops 22 Percent in 2007 and Cocaine Use Slows Dramatically, Reports Quest Diagnostics
8. Subordinate monkeys more likely to choose cocaine over food
9. Animal research suggests new strategy for treating cocaine addiction
10. Gene therapy reduces cocaine use in rats
11. Gene Therapy in Rats Reduces Cocaine Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...ican women using Carraguard had no decrease in inf...4 (HealthDay News) -- A microbicidal vaginal gel c...fection. , That,s the conclusion of a study tha...gative women at three sites in South Africa. , ...o gel and told to use one applicator of gel and a ...
(Date:12/4/2008)..., Dec. 4 Aurora Health Care is ram... D supplements. Aurora,s Care Management,Clinical...ucate all Aurora,caregivers about the benefits of...g evidence that higher Vitamin D levels may improv...porosis, certain muscle conditions and,seasonal d...
(Date:12/4/2008)...N, Dec. 4 The U.S. Gove...Development (USAID), is providing an additional $6...abwe. This assistance is in addition to the $4 mi...gram USAID is already implementing in Zimbabwe. ,... working alongside the international community to ...
(Date:12/4/2008)...cts similar to those seen with standard dose of da...c. 4 (HealthDay News) -- A high dose of the chemot...tients with previously untreated acute myeloid leu...red by the U.S. National Cancer Institute (NCI) sh...row. This study included 633 patients, aged 16 to ...
Breaking Medicine News(10 mins):Health News:Experimental Vaginal Gel Doesn't Ward Off HIV 2Health News:Aurora Health Care Urges All Wisconsin Residents to Take Vitamin D 2Health News:USAID Increases Assistance for Zimbabwe Cholera Outbreak 2Health News:Higher Chemo Drug Dose Prolongs Lives of Leukemia Patients 2
...ming at getting the children in northern communiti...h Promotion Minister, Jim Watson, the government w... carrot sticks, apples and other fresh fruit and v... children in elementary schools in Northern Ontari...
... found to have a role in the treatment of lung dis...cent research. // The results of the study have b...and Journal of Medicine, which has revealed that t...tment of cancer could slightly improve lung functi...
...o a vasectomy reversal could be at an increased ri...ead to birth defects in children. // The research...ersity, Bangkok, Thailand. The study was conducted...rocedure which does not interfere with sperm produ...
...daily doses of insulin injections. However in peop...f the pancreatic tissue// could help solve the pro...lindness, amputation, kidney failure, and heart di...early enough organ donors available for transplant...
Other Medicine News:Health News:Obesity Tackled at School Level 2Health News:Cancer Drug to Treat Scleroderma Lung Disease 2Health News:Vasectomy Reversal to Lead to Birth Defects 2Health News:Transplanted Pancreatic Tissue Could Help Diabetics 2
(Date:12/2/2008)...RNewswire-USNewswire/ -- Researchers using functio... in the area of the brain,responsible for suppres... from,stress-related psychiatric disorders. Resul...nual meeting of the Radiological Society of North ... depression and other stress-related disorders,t...
(Date:12/2/2008)... 2 Horizon Therapeutics, Inc., a,...nounced that two pivotal,Phase 3 trials evaluatin...501,met all primary endpoints. HZT-501, a novel,...ining ibuprofen and famotidine, demonstrated a,st... of non-steroidal,anti-inflammatory drug (NSAID)-...
(Date:12/1/2008)... TargeGen has announced that an ora...ti-center, US-based clinical,trial of TG101348 in...duled at,the 2008 American Society of Hematology ...ion are as follows:, Title: A P... JAK2-Selective Inhibitor, ...
(Date:12/1/2008)...s still the best policy , , ROCHESTER, Min...from Mayo Clinic finds the use of the drug therapy...titis, an acute inflammation of the liver caused b... the study are published in the December issue of ... ). , , VIDEO ALERT: Additional audio and ...
Breaking Medicine Technology:Stress-Related Disorders Affect Brain's Processing of Memory 2Stress-Related Disorders Affect Brain's Processing of Memory 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 1Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 2Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 3Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 4Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 5Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 6Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 7Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 8Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 9Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 10Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 11Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 12Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 13Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 14Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 15Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 16Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 17Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 18Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 19Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 20Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 21Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 22Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 23Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 24Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 25Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 26Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 27Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 28Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 29Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 30Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 31Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 32Oncolytics Biotech Inc Announces 2008 First Quarter Results 5000 33Cadence Pharmaceuticals CEO Ted Schroeder to Present at Three Investment Conferences During the Month of May 2008 4998 1Cadence Pharmaceuticals CEO Ted Schroeder to Present at Three Investment Conferences During the Month of May 2008 4998 2ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing 1948 1ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing 1948 2ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing 1948 3ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing 1948 4Genetic Changes May Dictate Course of Acute Myeloid Leukemia 18089 1Genetic Changes May Dictate Course of Acute Myeloid Leukemia 18089 2Genetic Changes May Dictate Course of Acute Myeloid Leukemia 18089 3
...tudy evaluating a clinically relevant model of,nor...gent capable,of abrogating the cytotoxic effect of...d OPTISOME(tm) agent was generally well,tolerated ...ent,profile similar to conventional vincristine , ...EWSWIRE) --,Hana Biosciences (Nasdaq:HNAB), a biop...
..., NJ – June 4, 2007 – Genta,Incorporat...sults,from a Phase 2 clinical trial of its markete..., plus rituximab (Rituxan®;,Genentech/IDEC) an...ctory non-Hodgkin’s lymphoma (NHL). The data...can Society of Clinical,Oncology (ASCO) in Chicago...
Other Medicine Technology:Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 2Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 3Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 4Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 5Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 2Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 3Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 4Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 5
Non-sterile Silicone Tubing
Anodized aluminum. Durable and lightweight with built-in protection against rust. Security locks ensure against accidental opening. Silicone matting/V-strips and bumper guards hold instruments in pla
Diamond knife tray with silicone inserts to securely hold the diamond knife.
Size: 6 x 10 inches. Depth: 7 inches. Sterilizable plastic tray with silicone matting for supporting and protecting instruments.
Medicine Products: